Veradermics, Inc. (MANE)
102.48
+4.02
(+4.08%)
USD |
NYSE |
Aug 25, 14:51
Veradermics Price : 102.48 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 100.00 | 102.75 | 93.81 | 98.46 | 717278.0 |
| Aug 21, 2026 | 105.18 | 108.87 | 102.52 | 102.82 | 393617.0 |
| Aug 20, 2026 | 111.00 | 111.39 | 101.69 | 105.32 | 773147.0 |
| Aug 19, 2026 | 114.50 | 117.40 | 110.07 | 111.23 | 748361.0 |
| Aug 18, 2026 | 106.40 | 111.57 | 106.40 | 111.31 | 464076.0 |
| Aug 17, 2026 | 111.28 | 111.28 | 106.08 | 108.22 | 581681.0 |
| Aug 14, 2026 | 110.28 | 113.52 | 109.84 | 112.71 | 523468.0 |
| Aug 13, 2026 | 108.75 | 111.98 | 107.37 | 111.00 | 571758.0 |
| Aug 12, 2026 | 108.23 | 111.86 | 104.98 | 109.05 | 1.360M |
| Aug 11, 2026 | 109.67 | 110.47 | 106.78 | 108.95 | 561902.0 |
| Aug 10, 2026 | 112.75 | 113.91 | 107.66 | 110.75 | 605060.0 |
| Aug 07, 2026 | 110.68 | 114.41 | 109.80 | 114.39 | 542268.0 |
| Aug 06, 2026 | 111.00 | 111.91 | 107.39 | 108.65 | 457094.0 |
| Aug 05, 2026 | 108.62 | 114.30 | 107.68 | 111.34 | 936182.0 |
| Aug 04, 2026 | 102.93 | 107.82 | 98.56 | 107.28 | 1.703M |
| Aug 03, 2026 | 102.15 | 105.00 | 93.77 | 101.89 | 2.766M |
| Jul 31, 2026 | 103.47 | 107.64 | 101.74 | 105.00 | 918408.0 |
| Jul 30, 2026 | 106.45 | 111.07 | 104.25 | 104.63 | 684366.0 |
| Jul 29, 2026 | 110.19 | 114.22 | 107.50 | 107.76 | 447482.0 |
| Jul 28, 2026 | 112.78 | 117.08 | 108.58 | 111.54 | 988278.0 |
| Jul 27, 2026 | 111.05 | 116.09 | 110.25 | 111.42 | 554189.0 |
| Jul 24, 2026 | 115.40 | 117.93 | 109.27 | 109.51 | 533173.0 |
| Jul 23, 2026 | 108.24 | 116.61 | 108.22 | 115.86 | 394143.0 |
| Jul 22, 2026 | 108.45 | 113.63 | 108.19 | 109.85 | 350157.0 |
| Jul 21, 2026 | 107.01 | 112.90 | 106.83 | 109.49 | 513296.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1239.38 |
| EyePoint, Inc. | 5.02 |
| Elanco Animal Health, Inc. | 25.14 |
| Tarsus Pharmaceuticals, Inc. | 71.82 |
| Amylyx Pharmaceuticals, Inc. | 37.36 |
Price Related Metrics
| PEG Ratio | -0.1116 |
| Price to Book Value | 5.259 |
| Earnings Yield | -2.54% |
| Market Cap | 4.282B |
| PEGY Ratio | -0.1116 |